3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and Supranuclear Palsy, Progressive

3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide has been researched along with Supranuclear Palsy, Progressive in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	3 (42.86)	18.2507
2000's	1 (14.29)	29.6817
2010's	3 (42.86)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Forsgren, L; Holmberg, H; Jakobson Mo, S; Larsson, A; Linder, J; Riklund, K	1
Liao, MH; Lin, KJ; Lin, WY; Lu, CS; Shen, LH; Weng, YH; Yen, TC	1
Hattori, N; Li, Y; Motoi, Y; Nakanishi, A; Ogaki, K; Shimizu, N; Takanashi, M; Tomiyama, H; Yokoyama, K	1
Arnold, G; Kraft, E; Oertel, WH; Schwarz, J; Tatsch, K	1
Janssen, AG; Kuiper, MA; Speelman, JD; van Royen, E; Verhoeff, NF; Wolters, EC	1
Hondl, N; Ladurner, G; Staffen, W; Trinka, E; Zenzmaier, R	1
Cordes, M; Felix, R; Harisch, C; Hierholzer, J; Hosten, N; Keske, U; Mäurer, J; Poewe, W; Richter, W; Schelosky, L; Venz, S	1

Trials

1 trial(s) available for 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and Supranuclear Palsy, Progressive

Article	Year
Preliminary studies of differential impairments of the dopaminergic system in subtypes of progressive supranuclear palsy. Nuclear medicine communications, 2010, Volume: 31, Issue:11 Topics: Aged; Benzamides; Diagnosis, Differential; Dopamine; Dopamine Plasma Membrane Transport Proteins; Female; Humans; Male; Middle Aged; Organotechnetium Compounds; Pyrrolidines; Receptors, Dopamine D2; Supranuclear Palsy, Progressive; Synapses; Tomography, Emission-Computed, Single-Photon; Tropanes	2010

Article

Year

Preliminary studies of differential impairments of the dopaminergic system in subtypes of progressive supranuclear palsy.

Nuclear medicine communications, 2010, Volume: 31, Issue:11

Topics: Aged; Benzamides; Diagnosis, Differential; Dopamine; Dopamine Plasma Membrane Transport Proteins; Female; Humans; Male; Middle Aged; Organotechnetium Compounds; Pyrrolidines; Receptors, Dopamine D2; Supranuclear Palsy, Progressive; Synapses; Tomography, Emission-Computed, Single-Photon; Tropanes

2010

Other Studies

6 other study(ies) available for 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and Supranuclear Palsy, Progressive

Article	Year
Pre- and postsynaptic dopamine SPECT in idiopathic Parkinsonian diseases: a follow-up study. BioMed research international, 2013, Volume: 2013 Topics: Aged; Benzamides; Case-Control Studies; Dopamine; Dopamine Plasma Membrane Transport Proteins; Follow-Up Studies; Humans; Multiple System Atrophy; Parkinson Disease; Parkinsonian Disorders; Pyrrolidines; Supranuclear Palsy, Progressive; Synapses; Time Factors; Tomography, Emission-Computed, Single-Photon	2013
Visual grasping in frontotemporal dementia and parkinsonism linked to chromosome 17 (microtubule-associated with protein tau): a comparison of N-Isopropyl-p-[(123)I]-iodoamphetamine brain perfusion single photon emission computed tomography analysis with Movement disorders : official journal of the Movement Disorder Society, 2011, Feb-15, Volume: 26, Issue:3 Topics: Adult; Aged; Asparagine; Benzamides; Brain; Chromosomes, Human, Pair 17; Female; Hand Strength; Humans; Lysine; Male; Middle Aged; Parkinsonian Disorders; Pyrrolidines; Supranuclear Palsy, Progressive; tau Proteins; Tomography, Emission-Computed, Single-Photon	2011
Steele-Richardson-Olszewski-syndrome: reduction of dopamine D2 receptor binding relates to the severity of midbrain atrophy in vivo: (123)IBZM SPECT and MRI study. Movement disorders : official journal of the Movement Disorder Society, 2002, Volume: 17, Issue:3 Topics: Aged; Benzamides; Corpus Striatum; Dopamine Antagonists; Female; Humans; Iodine Radioisotopes; Magnetic Resonance Imaging; Male; Mesencephalon; Middle Aged; Pyrrolidines; Receptors, Dopamine D2; Severity of Illness Index; Supranuclear Palsy, Progressive; Tomography, Emission-Computed, Single-Photon	2002
Multiple system atrophy and progressive supranuclear palsy. Diminished striatal D2 dopamine receptor activity demonstrated by 123I-IBZM single photon emission computed tomography. Archives of neurology, 1993, Volume: 50, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Atrophy; Benzamides; Central Nervous System; Dopamine D2 Receptor Antagonists; Humans; Middle Aged; Parkinson Disease; Pyrrolidines; Receptors, Dopamine D2; Supranuclear Palsy, Progressive; Tomography, Emission-Computed, Single-Photon	1993
SPET investigations in extrapyramidal diseases using specific ligands. Nuclear medicine communications, 1997, Volume: 18, Issue:2 Topics: Adult; Aged; Benzamides; Brain; Cocaine; Dopamine Antagonists; Hepatolenticular Degeneration; Humans; Huntington Disease; Iodine Radioisotopes; Male; Middle Aged; Movement Disorders; Parkinson Disease; Pyrrolidines; Receptors, Dopamine D2; Reference Values; Supranuclear Palsy, Progressive; Tissue Distribution; Tomography, Emission-Computed, Single-Photon	1997
Loss of dopamine-D2 receptor binding sites in Parkinsonian plus syndromes. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1998, Volume: 39, Issue:6 Topics: Adult; Aged; Benzamides; Binding Sites; Contrast Media; Corpus Striatum; Female; Humans; Iodine Radioisotopes; Male; Middle Aged; Multiple System Atrophy; Observer Variation; Olivopontocerebellar Atrophies; Parkinson Disease; Pyrrolidines; Receptors, Dopamine D2; Reproducibility of Results; Supranuclear Palsy, Progressive; Syndrome; Time Factors; Tomography, Emission-Computed, Single-Photon	1998